Overview of Dr. Katz
Dr. Philip Katz is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. He received his medical degree from Wake Forest School of Medicine of Wake Forest Baptist Medical Center and has been in practice 39 years. Dr. Katz accepts several types of health insurance, listed below. He is one of 303 doctors at New York-Presbyterian Hospital and one of 303 doctors at New York-Presbyterian Hospital who specialize in Gastroenterology. He has more than 100 publications and over 500 citings.
Office
1283 York Ave
New York, NY 10021
Education & Training
- Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1979 - 1982
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1978
- Wake Forest University Baptist Medical CenterFellowship, Gastroenterology
Certifications & Licensure
- FL State Medical License 2023 - Present
- NY State Medical License 2017 - 2026
- PA State Medical License 1996 - 2018
- NC State Medical License 1978 - 2002
- MD State Medical License 1986 - 1996
- NJ State Medical License 1962 - 1993
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 1 citationsVonoprazan is Efficacious for Treatment of Heartburn in Non-erosive Reflux Disease: A Randomized Trial.Loren Laine, Stuart Spechler, Rena Yadlapati, Felice Schnoll-Sussman, Neila Smith
Clinical Gastroenterology and Hepatology. 2024-05-14 - 40 citationsVonoprazan Versus Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial.Loren Laine, Kenneth DeVault, Philip Katz, Stefan Mitev, John Lowe
Gastroenterology. 2023-01-01 - 275 citationsACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.Philip O. Katz, Kerry B. Dunbar, Felice Schnoll-Sussman, Katarina B. Greer, Rena Yadlapati
The American Journal of Gastroenterology. 2021-11-22
Lectures
- Proton Pump Inhibitors: How to Help Get Your Patients Off of ThemAGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/9/2018
- GERD – Weighing the Risks and BenefitsAGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/9/2018
- PPI Risks: Separating Fact From FictionAGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/7/2018
Press Mentions
- Phathom Pharmaceuticals Announces Positive Topline Results from Phase 3 PHALCON-NERD-301 Trial Evaluating Daily Dosing of Vonoprazan for Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)January 8th, 2023
- Dupilumab Effective for Eosinophilic Esophagitis up to 52 WeeksDecember 28th, 2022
- Higher BMI May Dampen Steroid Response in Eosinophilic EsophagitisDecember 5th, 2022
- Join now to see all
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AmeriHealth Direct POS
Amerihealth HMO
AmeriHealth PPO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Carelink Health Plans PPO
First Health PPOGreat West PPO
HealthAmerica HealthAssurance PPO
Horizon BCBS PPO
Humana ChoiceCare Network PPO
IBC Keystone HMO / POS
IBC Personal Choice PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: